Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Qiagen NV (NASDAQ:QGEN)

34.30
Delayed Data
As of Oct 19
 -0.10 / -0.29%
Today’s Change
23.92
Today|||52-Week Range
36.34
+22.52%
Year-to-Date
Exane Asset Management Buys AT&T Inc, Verizon Communications Inc, CNH Industrial NV, ...
Oct 13 / GuruFocus News - Paid Partner Content
Henry Schein Closes Merritt Buyout, Expands in Animal Health
Oct 12 / Zacks.com - Paid Partner Content
Henry Schein Gains on Strategic Buyouts, Cost Concern a Woe
Oct 13 / Zacks.com - Paid Partner Content
CryoLife to Buy JOTEC, Preliminary Revenue Result Out for Q3
Oct 12 / Zacks.com - Paid Partner Content
NuVasive's (NUVA) PRECICE System Gets Expanded FDA Approval
Oct 13 / Zacks.com - Paid Partner Content
QIAGEN Banks on Tie-Ups & Product Launches, Competition Rife
Oct 11 / Zacks.com - Paid Partner Content
Bruker (BRKR) at a 52-Week High: What's Driving the Stock?
Oct 13 / Zacks.com - Paid Partner Content
Is a Beat in Store for Abbott (ABT) This Earnings Season?
Oct 11 / Zacks.com - Paid Partner Content
Abbott Banks on FDA Approvals and Buyouts, Competition Rife
Oct 13 / Zacks.com - Paid Partner Content
QIAGEN Partners With CENTOGENE, Boosts Bioinformatics Suite
Oct 10 / Zacks.com - Paid Partner Content
LabCorp (LH) Strong on Strategic Planning, Competition Rife
Oct 12 / Zacks.com - Paid Partner Content
QIAGEN's QFT-Plus Launch to Boost Molecular Diagnostics Arm
Oct 06 / Zacks.com - Paid Partner Content